These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1352723)

  • 1. Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugs.
    Kay EA; Pullar T
    Br J Rheumatol; 1992 Jul; 31(7):477-83. PubMed ID: 1352723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
    Pope JE; Hong P; Koehler BE
    J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG
    Hosp Pract (Off Ed); 1989 Jun; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.
    Jobanputra P; Wilson J; Douglas K; Burls A
    Rheumatology (Oxford); 2004 Feb; 43(2):206-10. PubMed ID: 12923291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
    Farr M; Kitas G; Bacon PA
    Clin Rheumatol; 1988 Jun; 7(2):242-8. PubMed ID: 2901303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologists.
    Baum SK; Tracy IC; Henderson EH; Alarcón GS
    Arthritis Care Res; 1991 Mar; 4(1):48-51. PubMed ID: 11188587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are rheumatologists' treatment decisions influenced by patients' age?
    Fraenkel L; Rabidou N; Dhar R
    Rheumatology (Oxford); 2006 Dec; 45(12):1555-7. PubMed ID: 16690762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the monitoring and management of the side effects of antirheumatic drugs by means of laboratory tests.
    Simon CH; Dijkmans BA; Breedveld FC
    Clin Exp Rheumatol; 1997; 15(6):633-9. PubMed ID: 9444419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
    Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS
    Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of United States rheumatologists concerning effectiveness of disease-modifying antirheumatic drugs and prednisone in the treatment of rheumatoid arthritis.
    Wolfe F; Albert DA; Pincus T
    Arthritis Care Res; 1998 Oct; 11(5):375-81. PubMed ID: 9830881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory screening for side effects of disease modifying antirheumatic drugs in daily rheumatological practice.
    Simon CH; Vliet Vlieland TP; Dijkmans BA; Bernelot Moens HJ; Janssen M; Hazes JM; Franken HC; Vandenbroucke JP; Breedveld FC
    Scand J Rheumatol; 1998; 27(3):170-9. PubMed ID: 9645411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.
    Galindo-Rodriguez G; Avina-Zubieta JA; Fitzgerald A; LeClerq SA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interface Management between General Practitioners and Rheumatologists-Results of a Survey Defining a Concept for Future Joint Recommendations.
    Puchner R; Edlinger M; Mur E; Eberl G; Herold M; Kufner P; Puchner A; Puchner SE; Redlich K; Alkin A; Machold K
    PLoS One; 2016; 11(1):e0146149. PubMed ID: 26741702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-rheumatic drug-prescribing behaviour of Australasian rheumatologists 1984-1994.
    Conaghan PG; Crotty M; Oh E; Day RO; Brooks PM
    Br J Rheumatol; 1997 Apr; 36(4):487-90. PubMed ID: 9159546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing Patterns of Intravenous Golimumab for Rheumatoid Arthritis.
    Brady BL; Tkacz JP; Lofland J; Meyer R; Bolge SC
    Clin Ther; 2015 Sep; 37(9):2028-36. PubMed ID: 26210073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic and clinical study on combined immunomodulator therapy in rheumatoid arthritis].
    Hoshi K; Mizushima H
    Ryumachi; 1988 Dec; 28(6):457-9. PubMed ID: 2907949
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany].
    Thiele K; Buttgereit F; Huscher D; Zink A;
    Z Rheumatol; 2005 Apr; 64(3):149-54. PubMed ID: 15868331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical results of treatment with disease-modifying antirheumatoid drugs.
    Thompson PW; Kirwan JR; Barnes CG
    Br J Rheumatol; 1985 May; 24(2):167-75. PubMed ID: 3922462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.